Sorry, you need to enable JavaScript to visit this website.
Skip to main content

“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz. “Ending pay-for-delay settlements will help control drug costs. We’re delighted about the President’s resolute support for this bipartisan initiative.”

(JDL stmt)

Contact Information

MEDIA CONTACT:
Office of Public Affairs
202-326-2181